Black Diamond Therapeutics, Inc.
BDTX
$1.71
$0.010.59%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -948.77% | 132.10% | 129.41% | 117.93% | 106.38% |
| Total Depreciation and Amortization | -22.97% | -5.25% | 0.00% | -7.77% | -14.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 50.58% | 60.98% | -15.18% | -32.59% | 6.77% |
| Change in Net Operating Assets | -92.79% | -224.22% | -517.57% | -641.15% | -277.87% |
| Cash from Operations | -376.52% | 147.53% | 134.88% | 126.19% | 118.13% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -86.92% | -71.28% | -62.79% | 107.89% | 12.63% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -186.78% | -366.28% | -1,148.38% | 46.36% | 275.87% |
| Cash from Investing | -186.50% | -364.65% | -1,083.91% | 46.56% | 276.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.38% | -99.36% | -98.21% | -99.67% | -71.47% |
| Repurchase of Common Stock | -97.22% | -23.81% | 61.07% | -700.00% | -447.83% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -101.69% | -100.57% | -98.65% | -100.05% | -71.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -193.62% | 21.99% | 121.54% | 70.30% | 618.94% |